ON CRITERIA FOR THE EFFICIENCY OF TREATMENT FOR RHEUMATOID ARTHRITIS

ON CRITERIA FOR THE EFFICIENCY OF TREATMENT FOR RHEUMATOID ARTHRITIS

Bibliographic Details
Main Author:	Yuri Vladimirovich Muravyev
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-12-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1582

Similar Items

Methotrexate dosage in the treatment of rheumatoid arthritis
by: Yuri Vladimirovich Muravyev
Published: (2013-11-01)

Genetic engineering biologicals in the treatment of AA-amyloidosisin patients with rheumatoid arthritis
by: Yuri Vladimirovich Muravyev
Published: (2010-04-01)

How is folic acid to be used in rheumatoid arthritis during methotrexate treatment?
by: Yuri Vladimirovich Muravyev
Published: (2013-04-01)

Evolution of ideas on drug-induced tuberculosis in rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2010-04-01)

Current practice of methotrexate treatment for rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2012-08-01)

Rheumatoid arthritis classification criteria: debatable problems
by: Yu. V. Muravyev, et al.
Published: (2019-01-01)

Lung lesion caused by the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yuriy Vladimirovich Murav'ev, et al.
Published: (2010-12-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Discussion questions of national classification of rheumatoid arthritis
by: Y. V. Muravyev
Published: (2007-04-01)

NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2015-09-01)

Clinimetric criteria of rheumatoid arthritis
by: Domenico Galasso, et al.
Published: (2012-10-01)

Significance of SAA1 gene polymorphism in the development of AA amyloidosis in patients with rheumatoid arthritis in the Moscow population
by: V A Myakotkin, et al.
Published: (2012-08-01)

New classification criteria for rheumatoid arthritis
by: R. Caproali, et al.
Published: (2011-06-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

Classification of rheumatoid arthritis: is it time to revise the criteria?
by: Lieve Van Hoovels, et al.
Published: (2024-04-01)

Trends in the idea of the safety of glucocorticoids in rheumatoid arthritis
by: Yu V Murav'ev, et al.
Published: (2011-04-01)

Interstitial lung involvement in rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2014-12-01)

Systemic manifestations of rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2013-02-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

Evaluation of the modified combined glucocorticoid toxicity index in rheumatoid arthritis: Preliminary data
by: V. V. Lebedeva, et al.
Published: (2020-02-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

THE IMPACT OF ADEQUATE PSYCHOPHARMACOTHERAPY ON THE EFFICIENCY OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2018-05-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Efficiency of Biofeedback Therapy in Complex Treatment of Rheumatoid Arthritis Patients
by: Grekhov Rostislav Aleksandrovich, et al.
Published: (2015-09-01)

INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01)

Selection of key criteria for assessment tools for patients with rheumatoid arthritis
by: Anzhela Nogas, et al.
Published: (2018-02-01)

The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis
by: Yu. V. Muravyev, et al.
Published: (2018-09-01)

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

PROBLEMA NEBLAGOPRIYaTNYKh REAKTsIYNA LEKARSTVENNYE PREPARATY
by: Yuri Vladimirovich Muravyev
Published: (2010-06-01)

ZNAChENIE LEKARSTVENNYKh PREPARATOV V RAZVITIIPROGRESSIRUYuShchEY MNOGOOChAGOVOY ENTsEFALOPATIIPRI REVMATIChESKIKh ZABOLEVANIYaKh
by: Yuri Vladimirovich Muravyev
Published: (2010-08-01)

GENNO-INZhENERNYE BIOLOGIChESKIE PREPARATY I VIRUSNYY GEPATIT V U BOL'NYKh REVMATOIDNYM ARTRITOM
by: Yuri Vladimirovich Muravyev
Published: (2010-10-01)

Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis
by: Vladimir Iosifovich Konenkov, et al.
Published: (2010-12-01)

Bishofit in the treatment of rheumatoid arthritis
by: А В Zborovsky, et al.
Published: (2003-05-01)

EFFICIENCY OF PHOTOMAGNETIC THERAPY IN RHEUMATOID ARTHRITIS
by: Voichenko N. V., et al.
Published: (2020-06-01)

Comparing new diagnostic criteria of 2010 ACR/EULAR with 1987 ACR criteria in rheumatoid arthritis
by: Fatemeh Shirani, et al.
Published: (2017-01-01)

Factors associated with rs1801394 of the methionine synthase reductase gene polymorphism in patients with rheumatoid arthritis
by: M. Yu. Krylov, et al.
Published: (2021-06-01)

Treatment of vasculitis in rheumatoid arthritis.
by: Luqmani, R, et al.
Published: (1994)

Etanercept for the treatment of rheumatoid arthritis.
by: Lethaby, A, et al.
Published: (2013)

Filgotinib for the treatment of rheumatoid arthritis
by: Taylor, P, et al.
Published: (2017)